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α-haemolysin (HlyA)-producing Escherichia coli commonly inflict severe urinary tract
infections, including pyelonephritis, which comprises substantial risk for sepsis. In vitro,
the cytolytic effect of HlyA is mainly mediated by ATP release through the HlyA pore
and subsequent P2X1/P2X7 receptor activation. This amplification of the lytic process
is not unique to HlyA but is observed by many other pore-forming proteins including
complement-induced haemolysis. Since free hemoglobin in the blood is known to be
associated with a worse outcome in sepsis one could speculate that inhibition of P2X
receptors would ameliorate the course of sepsis. Surprisingly, this study demonstrates
that P2X
−/−
7 and P2X
−/−
4 mice are exceedingly sensitive to sepsis with uropathogenic
E. coli. These mice have markedly lower survival, higher cytokine levels and activated
intravascular coagulation. Quite the reverse is seen in P2X
−/−
1 mice, which had
markedly lower cytokine levels and less coagulation activation compared to controls
after exposure to uropathogenic E. coli. The high cytokine levels in the P2X
−/−
7 mouse
are unexpected, since P2X7 is implicated in caspase-1-dependent IL-1β production.
Here, we demonstrate that IL-1β production during sepsis with uropathogenic E. coli
is mediated by caspase-8, since caspase-8 and RIPK3 double knock out mice show
substantially lower cytokine during sepsis and increased survival after injection of TNFα.
These data support that P2X7 and P2X4 receptor activation has a protective effect during
severe E. coli infection.
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INTRODUCTION
Sepsis is the major cause of death in intensive care units
worldwide. Urinary tract infections (UTI), often caused by
uropathogenic E. coli, have been identified as the prime source
in ∼10–30% of severe sepsis or septic shock (Wagenlehner et al.,
2007). Sepsis in general can result in multiple organ failure and
death as a consequence of uncontrolled activation of the innate
immune system with high circulating levels of pro-inflammatory
cytokines such as interleukin 6 (IL-6), IL-8, IL-1β and tumor
necrosis factor α (TNFα) (Nupponen et al., 2001; Santana et al.,
2015). In addition to cytokines, adenosine triphosphate (ATP)
comprises one of many host damage-associated-molecular-
patterns (DAMPs) molecules released to the extracellular space
during cell injury in response to invasive pathogens (Land et al.,
2016; Ousingsawat et al., 2017). The level of extracellular ATP
is sensed by P2Y and P2X receptors and serves a wide range
of physiological functions including thrombocyte aggregation,
taste, pain, and chemo-sensing (Burnstock, 2009). In terms of
infection, ATP is a well-recognized signaling molecule released
at sites of inflammation/cell injury, and plays a central role in
immune cell migration, chemotaxis, and cytokine release (Junger,
2008; Bours et al., 2011). In particular, the P2X7 receptor has
attracted considerable attention for its importance in immune
cell communication (Di Virgilio and Vuerich, 2015), release of
pro-inflammatory cytokines (Suzuki et al., 2004; Clark et al.,
2010; Shieh et al., 2014; Trubiani et al., 2014), and recruitment of
macrophages and lymphocytes (Moncao-Ribeiro et al., 2011; da
Silva et al., 2013). Therefore, the P2X7 has emerged as a potential
anti-inflammatory therapeutic target.
We have previously established that the effect of the pore-
forming virulence factor α-haemolysin (HlyA), secreted from
certain E. coli strains, is mainly secondary to ATP release and P2X
receptor activation (Skals et al., 2009). E. coli strains that produce
HlyA are commonly isolated from patients with severe urinary
tract infections (Johnson, 1991; Bien et al., 2012) and contribute
to the pathogenesis of urosepsis. In vitro, we have demonstrated
in erythrocytes that ATP is released immediately after HlyA is
inserted into the membrane (Skals et al., 2014) and potentiates
haemolysis by activation of mainly P2X1 in mice and mainly
P2X7 receptors in humans (Skals et al., 2009). Importantly, the
P2X-dependent amplification of cell damage is not specific to
HlyA but is seen in response to many types of cytolytic proteins
such as α-toxin from S. aureus (Skals et al., 2011), LtxA from
A. actinomycetemcomitans (Munksgaard et al., 2012), ApxIA
haemolysin from A. pleuropneumoniae (Masin et al., 2013), β-
toxin fromC. perfringens (Nagahama et al., 2015), andmembrane
attack complex formed after complement activation (Hejl et al.,
2012). Based on this, we speculated that P2X receptor antagonists
may ameliorate the symptoms of urosepsis.
Urosepsis is not easily modeled experimentally as installation
of bacteria in the urinary tract is unable to produce reproducible
septic events in rodents. However, direct injection of
uropathogenic bacteria intravenously has been proven to be a
beneficial model for urosepsis (Barber et al., 2016). The chosen
uropathogenic bacterium (ARD6, O6:K13:H1) commonly causes
urinary tract infection in humans and, in addition to HlyA, also
expresses other virulence enhancing proteins such as P-fimbriae
(Zingler et al., 1992).
In this study, we used a model of acute sepsis in P2X1, P2X4,
and P2X7 receptor deficient mice under anesthesia using these
uropathogenic E. coli, in accordance with Danish legislation
for animal research. We establish that mice lacking P2X7
and P2X4 are significantly more susceptible to sepsis inflicted
by uropathogenic E. coli. P2X
−/−
7 and P2X
−/−
4 mice died
more quickly and showed massively increased plasma cytokine
levels, intravascular haemolysis and activation of the coagulation
system. Strikingly, we found a markedly smaller spleen in
P2X
−/−
7 mice compared to P2X
+/+
7 even though the spleen
just like the control enlarged during sepsis. The P2X
−/−
1 mice
seemed relatively protected against sepsis with uropathogenic
E. coli with prominently lower plasma cytokine levels. The
unexpected, high IL-1β-production in the P2X
−/−
7 mice is likely
to result from P2X7-independent activation of caspase-8 (casp8),
since casp8/RIPK3 double knock out mice exhibit markedly
lower cytokine levels compared to controls during sepsis with
uropathogenic E. coli. These data support that P2X7 and P2X4
receptor activation protects against severe infection either by
limiting the number of bacteria in the blood or by diminishing
the casp8 dependent cytokine storm.
MATERIALS AND METHODS
Escherichia coli
The uropathogenic E. coli strain ARD6 (serotype: O6:K13:H1)
and the non-pathogenic strain D2103 (serotype OR:H48) were
obtained from Statens Serum Institute (Copenhagen, Denmark).
The bacteria were grown on agar plates containing LB media
and kept for up to 1 month at 4◦C. For each experiment a
fresh liquid preparation of E. coli was cultured overnight by
transferring one colony to 4 ml LB medium at 37◦C at 250
rpm. The following morning, the culture was centrifuged twice
and re-suspended in sterile saline. Live and dead bacteria in
this preparation were distinguished by a cell viability kit (BD
biosciences) and approximately 10% dead cells were present in
this type of preparation. E. coli was counted by flow cytometry
(Accuri C6, BD Biosciences) and different concentrations of
bacteria were used depending on the specific mouse strain the
protocol used (see section “mouse model of sepsis” below). In all
experiments, isolated bacteria were injected into mice via a lateral
tail vein in 150 µl saline.
Animals
P2X7
−/− mice on a balb/cj background (over 10 generation
back crossed) were bred at the Institute of Biomedicine, Aarhus
University and matched with either P2X
+/+
7 littermates from
heterozygous breeding or balb/cj mice from Janvier Labs (Saint-
Berthevin, France). The P2X
−/−
7 mice were originally developed
by GlaxoSmithKline and bred into the balb/cj background.
Animal experiments with the P2X antagonists, BBG, were
performed on balb/cj mice from Janvier Labs.
P2X1 and P2X4 wild type and knockout mice were bred at
the Institute of Biomedicine, Aarhus University, by heterozygous
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breeding and littermates were used. P2X1 mice were on a
C57BL/6J background and P2X4 were on a mixed background
(C57BL6.b6129s). All P2X mice used in this study were 8–10
week old males with a weight of 25.1± 0.8 g.
Caspase-8/RIPK-3−DKO mice were bred in the Kiel facility,
Germany, as published (Linkermann et al., 2013), and matched
with C57BL/6N mice from either Charles River, Sulzfeld or
Janvier Labs. The authors would like to thank NR Jorgensen for
providing the P2X7 mice, J Leipziger for providing the P2X4
mice, D Green for providing the casp8/RIPK3DKO (Oberst et al.,
2011), V. Dixit and K. Newton (Genentech) for providing RIPK3
deficient mice (Newton et al., 2004) and R Hakim for casp8
heterozygous mice (Salmena et al., 2003).
Blood Samples
Immediately before the mice were euthanised, blood was drawn
from the abdominal vena cava into a heparinised syringe and
centrifuged at 1,000 g for 10 min to obtain plasma. Plasma
was used for measurements of intravascular haemolysis, levels
cytokines and thrombin-antithrombin complexes.
Haemolysis
Haemolysis was measured immediately as the absorbance at
410 nm (dilution 1:32) on a spectrophotometer (Ultraspec III,
LKB Biochrom) and the value evaluated by reference curve.
The remaining plasma was stored at −20◦C for later evaluation
of cytokines and levels of thrombin-antithrombin complexes.
Plasma was stored and used within 30 days.
Reagents
Brilliant Blue G (BBG) was from Sigma-Aldrich and NF449 was
from Tocris Bioscience (Bristol, UK). Purified murine TNFα
was purchased from BioLegend (Uithoorn, Netherlands). All
substances were dissolved in sterile isotonic saline (0.9% NaCl).
CBA flex sets for measuring cytokines were from BD Biosciences.
TAT Complexes Mouse ELISA Kit for measuring levels of
thrombin-antithrombin was from Abcam (Cambridge, UK).
Cytokines
TNF-α, IL-1β, KC (murine equivalent of IL-8 in humans), IL-
6 were measured on stored plasma samples (−20◦C) on a
flow cytometer (BD Accuri C6, BD Biosciences) according to
manufactures instructions.
Thrombin-Antithrombin (TAT) Complexes
TAT were measured in heparin-anticoagulated plasma
samples with TAT Complexes Mouse ELISA Kit according
to manufactures instructions.
Mouse Model of Sepsis
Sepsis was induced in mice on three different backgrounds
(balb/cj, C57BL/6rj and mixed). The number of bacteria required
to investigate survival rates within 6 hwere adjusted to an optimal
number of 165·106 in balb/cj mice. However, we observed
that mice on a C57BL/6rj and mixed background required a
higher number of bacteria to die within the observation period.
Thus, the number of bacteria was increased by a factor 1.5,
corresponding to 248·106. These concentrations will be referred
to as high doses in the result section. The high doses were
decreased by a factor 0.25 corresponding to ∼ 41·106 for balb/cj
and 62·106 for C57bl/6j and mixed backgrounds and will be
referred to as the low doses in the result section. All mice were
anesthetized by a subcutaneous injection of ketamine (100mg
kg−1) and xylazine (7.5mg kg−1) and placed on a heating plate
at 38◦C. E. coli was injected in a lateral tail vein in a volume
of 150 µl sterile saline and mice were monitored carefully for
either 2.5 or 6 h according to the protocol used. For both
protocols, additional anesthesia was administered approximately
every 45 min. Body temperature was measured continuously by a
rectal thermometer (Bioseb, Florida, USA). Blood pressure was
measured every 30 min by determining the tail blood volume
with a volume-pressure recording sensor and an occlusion
tail-cuff (Kent Scientific Corporation, Connecticut, USA) and
respiratory rate (RR) was visually monitored every 30 min. BBG,
NF449 or saline were given 2 h before and 2 and 4 h after E.
coli injection. BBG was given subcutaneously and NF449 was
given iv.
The following 3 protocols were used in this study:
Survival—6 h: Mice were continuously observed after E. coli
injection in the tail vain. Mice were given injections of
BBG, NF449 or saline. Body temperature, blood pressure and
respiratory rate were monitored. 165·106 ARD6 was given to
the mice on balb/cj background and 248·106 ARD6 was given
to C57BL6 and mixed background. In the following these
concentrations will be referred to as the high dose of E. coli.
Harvesting blood and organs—2.5 h—high dose: Mice were
continuously observed after E. coli injection and organs and
blood were harvested after 2.5 h. Mice were given injections of
BBG, NF449 or saline. Body temperature, blood pressure and
respiratory rate were monitored. ARD6 (165·106) was given to
mice on balb/cj background and 248·106 ARD6 was given to
C57BL/6j and mixed background. Harvesting blood—2.5 h—low
dose: Mice were continuously observed after E. coli injection and
the blood was harvested after 2.5 h. Body temperature, blood
pressure and respiratory rate were monitored. ARD6 (41·106)
was given to mice on balb/cj background and 62·106 ARD6 was
given to C57BL/6j and mixed background. In the following these
concentrations will be referred to as the low dose of E. coli.
TNFα-induced shock—Themodel of TNFα-induced shock has
been described in detail previously (Cauwels et al., 2003). In our
experiments, C57BL/6N, RIPK3-deficient and casp8/RIPK3DKO
mice received a single iv-injection of 25mg kg−1 murine TNFα
(in 200 µl PBS) via the tail vein. Animals were under permanent
observation and survival was checked every 15min in accordance
to the authorisation of the local committee for the preservation of
animals act.
Colony Forming Units (CFU)
CFU were determined in blood after the animals were sacrificed.
Whole blood (10 µl) was diluted 1/100 and 5 µl was plated on a
blood agar plate and cultured overnight at 37◦C and the number
of colonies were counted and expressed as CFU µl blood−1.
Histology
Organs were isolated after euthanasia. Lungs, liver, spleen,
kidneys and heart were immersion fixed in 4% paraformaldehyde
for at least 24 h and stored at 4◦C until further preparation.
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For preparation, the organs were dehydrated in a series of three
ethanol solutions (70, 96, and 99.9%), xylen and then imbedded
in paraffin for haematoxylin eosin (HE) staining.
Spleen Weight
The spleens were dissected free from connecting tissues. The
weight of each spleen was determined and the result expressed
as percentage of body weight.
Ethics
The experiments performed in this study were approved
by Danish ethic committee for animal research
“Dyreforsøgstilsynet” (2014-15-0201-00316) and by the
local committee for the preservation of animal act of
Christian-Albrechts-University Kiel, Germany.
Statistics
Statistical analysis was performed using GraphPad Prism
software. Survival studies were analyzed by Kaplan-Meier curve
and log-rank test. All other data was reported as mean ± SEM
and analyzed using Student t-test. A p < 0.05 was considered
statistically significant and marked by ∗.
RESULTS
The present study was undertaken to determine the in vivo
effects of uropathogenic E. coli during sepsis. Specifically, we
were interested in the role of P2X1 and P2X7 because these
receptors are predominantly responsible for the cytotoxic effects
of HlyA in vitro. Moreover, we included the P2X4 receptor
because it is expressed in most bone marrow derived cells and
because it is hard to distinguish pharmacologically from P2X7.
To this end, we used mice deficient of the given receptors and
or pharmacological blockage of P2X1 and P2X7 receptors. Sepsis
was induced in anesthetized mice by iv-injection of the HlyA-
producing and uropathogenic E. coli strain ARD6. Mice were
kept under anesthesia to follow regulations by the Danish ethic
committee for animal research.
Establishing a Sepsis Model in Mice
Mice exposed to ARD6 develop bacteraemia demonstrated by
colony forming units on blood culture. This was not seen in
control mice injected with saline. In addition, balb/cj mice
subjected to iv-injection of a high dose of ARD6 (165·106)
showed an increase in body temperature over the observation
period of 2.5 h (Figure S1A). Moreover, animals exposed to
bacteria developed haematuria and clearly showed acute tubular
necrosis. The inner renal medulla showed obvious protein
deposits in the lumen of the renal tubules in the animals
exposed to ARD6 (Figure S2). Taken together these observations
indicate septic shock. To distinguish the effect of uropathogenic
E. coli, we included a non-pathogenic control strain of E. coli
(D2103, OR:H48), which in contrast to ARD6 does not cause
pyelonephritis in mice after injection into the urinary bladder
(unpublished observations). When balb/cj mice were injected
with an equal amount D2103 (165·106), all mice survived the 6-
h observation period (Figure S3A). Moreover, mice subjected to
D2103 did not show intravascular haemolysis and only very slight
changes in plasma cytokine levels (Figures S3B,C).
Role of P2X7 Receptors in ARD6 Sepsis
We investigated the role of the P2X7 receptor in this sepsis
model over a 6-h observation period. Surprisingly, we found
a significant reduction in the survival of the P2X
−/−
7 mice
compared to P2X
+/+
7 (Figure 1A). The average survival time
was 323.3 ± 18.5 min for P2X
+/+
7 and 214.9 ± 24.2 min for
P2X
−/−
7 mice after a high dose of ARD6 (p = 0.0027). We
also observed a significantly higher intravascular haemolysis
in P2X
−/−
7 mice compared to P2X
+/+
7 controls (Figure 1B),
corresponding to approximately 12 and 3% in P2X
−/−
7 and
P2X
+/+
7 mice, respectively (Figure S1B). The bacterial load was
FIGURE 1 | P2X7 deficiency in E. coli-induced sepsis. ARD6 was injected into anesthetized P2X
+/+
7 and P2X
−/−
7 mice (high dose—165 million bacteria). (A)
Kaplan-Meier plot shows survival after ARD6 injection, n = 6 for controls and 10–12 for ARD6 for each genotype. (B) Absorbance of plasma as an indication of
plasma haemolysis 2.5 h after ARD6 injection, n = 5 for control and 10–12 for each genotype. (C) Colony forming units (CFU) in the blood 2.5 h after ARD6 infection,
n = 4 for controls and 11 for both genotypes. *p < 0.05.
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seemingly, higher in blood drawn from P2X
−/−
7 mice at the
end of the experiment (Figure 1C). This did, however, not reach
statistical significance compared to P2X
+/+
7 , because of a large
inter-animal variation. This does, however, support that P2X7
receptor activation has been associated with increased bacterial
macrophage-mediated bacterial clearance during sepsis (Csoka
et al., 2015). Animals exposed to bacteria clearly showed acute
renal tubular necrosis (Figure S2) in 80% of the mice exposed to
ARD6 with no marked difference between P2X
+/+
7 and P2X
−/−
7 .
Haematuria was observed in 90% of the P2X
−/−
7 mice and 30%
of the P2X
+/+
7 mice following ARD6 exposure. This could be
a simple consequence of higher haemolysis in P2X
−/−
7 mice,
however, it potentially suggests damage to the filtration barrier.
In support of this notion, amorphous protein was observed in the
tubular lumen of 40% P2X
+/+
7 and 63% P2X
−/−
7 mice exposed to
ARD6; this was most obvious in the renal medulla (Figure S2B).
None of the P2X
+/+
7 or P2X
−/−
7 mice exposed to saline showed
any evidence of tubular necrosis or debris in the tubular lumen
(Figure S2). Interestingly, this sepsis model caused quite dramatic
changes in the morphology of the spleen (Figure 2A). In the
mice injected with saline, the spleen appeared normal, dominated
by large blue areas following HE staining of the white pulp.
After ARD6 treatment, the ratio between white and red pulp
changed markedly, apparently with a reduction of the marginal
zone reducing the overall diameter of the white pulp. This could
result from mobilization of B and T cells from the spleen during
infection, since this has been demonstrated in spleens from septic
patients (Hotchkiss et al., 2001; Gunia et al., 2005). However, it
could potentially also reflect increased binding and phagocytosis
of damaged red blood cells in the red pulp overshadowing
the white pulp and thus, changes the ratio between the two.
The low white/red pulp is seen in 80% of the spleen from
P2X
+/+
7 mice and in 63% of the spleen from P2X
−/−
7 mice. This
could theoretically suggest that splenic monocytes/macrophages
are unable to recognize HlyA-induced erythrocyte damage in
P2X
−/−
7 mice, as previously suggested (Fagerberg et al., 2013).
We also measured spleen to body weight ratio and found a
substantial increase in spleen mass after injection of ARD6 both
in the P2X
+/+
7 and in P2X
−/−
7 (Figure 2B). The mean increase
was 0.06% of body mass in P2X
+/+
7 and 0.12% of body mass in
P2X
−/−
7 mice. Mice pre-treated with BBG did not exhibit any
enlargement of the spleen upon exposure to ARD6. Remarkably,
the saline treated P2X
−/−
7 mice had a significantly smaller spleen
compared to saline-injected P2X
+/+
7 (Figure 2B). Therefore, we
measured spleen sizes in untreated P2X
+/+
7 and P2X
−/−
7 mice
and found that the P2X
−/−
7 mouse indeed had a significantly
smaller spleen compared to P2X
+/+
7 (Figure 2C).
Based on the survival curves, one would expect the cytokine
levels to differ between the genotypes. However, although the
level of TNFα, KC, IL-1β, and IL-6 were highly elevated 2.5 h
after administrating 165·106 ARD6, they did not differ between
the two genotypes (Figure S4). We speculated that the bacteria
load may cause a ceiling effect, and masks any difference in
cytokine levels between the genotypes. Therefore, we measured
cytokine levels after exposing mice to a reduced dose of ARD6
(41·106). In this situation, IL-6 and IL-1β were distinctly higher
in the P2X
−/−
7 mice compared to controls (Figure 3A), whereas
TNFα and KC was not statistically significantly different between
the groups. Thus, the higher mortality in the P2X
−/−
7 mouse is
associated with higher cytokine release, supporting previous data
that massive cytokine storm is associated with disadvantageous
outcome of sepsis (London et al., 2010; Weber et al., 2015).
High cytokine levels are associated with the severity of sepsis
and development of disseminated intravascular coagulation (for
review see Gando et al., 2016). Interestingly, we found markedly
higher levels of thrombin-antithrombin (TAT) complexes in
plasma from P2X
−/−
7 compared to P2X
+/+
7 mice (Figure 3B),
which indicates enhanced activation of the coagulation cascade in
thesemice. Coincidently, we observed that the buffy coat in blood
samples from P2X
−/−
7 mice exposed to ARD6 was almost un-
detectable (data not quantified). This could potentially suggest
infection-induced depletion of thrombocytes in P2X
−/−
7 mice
and support the notion of massively activated coagulation system
in these mice.
To support the data from the P2X
−/−
7 mouse, we tested
the well-known P2X antagonist Brilliant Blue G (BBG) that
has some selectivity toward P2X7 in wild type balbc/j mice.
BBG was chosen because the color allows us to directly
measure the antagonist concentration in plasma. BBG was given
subcutaneously (50mg kg−1) 2 h prior to the iv-injection of
ARD6 and the mice were observed for 6 h under anesthesia,
subsequently surviving mice were culled. At the end of the 6 h
period the plasma level of BBG was determined to be 1.2 µM,
well above the 1µMneeded to block P2X7 receptors. BBG treated
mice showed a tendency toward an increased survival rate but
this was not statistically significant (Figure 4A). Similar to the in
vitro experiments (Skals et al., 2009), BBG inhibited haemolysis
in vivo (Figure 4B). BBG had no statistically significant effect
on the number of bacteria in the blood (Figure 4C) but caused
a significant decrease in TNFα and IL-1β after injection of
41 million ARD6 and no significant effect on KC or IL-6
(Figure 4D). Thus, pre-treatment with BBG does not mimic the
phenotype of the P2X7 receptor deficient mice.
Role of P2X1 and P2X4 in ARD6 Sepsis
BBG is not completely selective for P2X7 receptors, and has
been shown to antagonize both P2X1 and P2X4 receptors (Jiang
et al., 2000; Seyffert et al., 2004). This may potentially explain the
discrepancy between the P2X
−/−
7 mice and the wild type mice
treated with BBG. Therefore, we compared the outcome of sepsis
in P2X1 and P2X4 deficient mice.
Mice on a C57BL/6 background required a markedly higher
number of bacteria to develop lethal sepsis within the observation
period. We did not observe any difference in mortality between
P2X
+/+
1 and P2X
−/−
1 mice after a high dose of ARD6
(Figure 5A). On average, however, the P2X
−/−
1 survived 57
min longer compared to the P2X
+/+
1 . The P2X1 antagonist
NF449 showed a tendency toward an increase in survival, but
this was not statistically significant (Figure 5B). It must be
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FIGURE 2 | E. coli-induced sepsis—effects on the spleen. (A) Sections of spleens from P2X7
+/+ or P2X
−/−
7 mice exposed to either saline or ARD6 (high
dose—165 million). ARD6 or saline were injected iv and the animals were observed for 2.5 h before they were sacrificed. Organs were harvested and prepared for
haematoxylin-eosin (HE) staining. Images are representative of 8 experiments. (B) Dissected spleens from P2X
+/+
7 and
−/− mice after saline, ARD6, or ARD6 and
BBG treatment, n = 4–8. (C) Dissected spleens from untreated P2X
+/+
7 and
−/− mice, n = 8 in both groups. *p < 0.05.
noted that NF449 is degraded quickly (Hechler et al., 2005)
and thus, may not provide full P2X1R inhibition during the
experiment. In a parallel series of experiments in P2X
+/+
1 and
P2X
−/−
1 mice, intravascular haemolysis, TAT and cytokine levels
were measured in plasma 2.5 h after a low dose of ARD6.
Intriguingly, TNFα, IL-1β, and IL-6 and TAT levels were all lower
in the P2X
−/−
1 compared to P2X
+/+
1 (Figures 5D,E), whereas
intravascular haemolysis was similar in the two genotypes
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FIGURE 3 | P2X7 deficiency and E. coli-induced sepsis. ARD6 was injected into anesthetized P2X
+/+
7 and P2X
−/−
7 mice (low dose—41 million). (A) plasma
TNFα, KC, IL-1β, and IL-6 measured 2.5 h after ARD6 injection, n = 7–8 for controls and 8–9 for each genotype. (B) Plasma thrombin-antithrombin (TAT)
complexes—measured 2.5 h after ARD6 injection, n = 6–7 for controls and 10–11 for both genotypes. *p < 0.05.
(Figure 5C). Notably, P2X1 receptor expression has a positive
impact on the cytokine storm inflicted by the bacterial infection
and thus, any P2X1antagonizing effect of BBGmay potentially be
responsible for the lower cytokine levels observed during sepsis
in animals pre-exposed to BBG.
P2X4—Similar to our findings in P2X
−/−
7 mice, P2X
−/−
4 mice
showed decreased survival when exposed to a high dose of
ARD6 compared to P2X
+/+
4 controls (Figure 6A). Moreover,
we found higher intravascular haemolysis, plasma IL-1β levels
as well as higher TAT levels in the P2X
−/−
4 after a low ARD6
dose compared to control (Figures 6B–D). Thus, the data on
this knock out mouse in many ways resembles data obtained
in the P2X
−/−
7 mice and supports the notion that mice with
high cytokine levels in plasma are more prone to die of sepsis.
These data also support that mice deficient in P2X4 and P2X7
receptor are more sensitive to acute severe infection and that this
sensitivity is not a result of reduced immune reaction.
Casp8 and Receptor-Interacting-Protein-3
(RIPK3) in ARD6 Sepsis and TNFα Shock
IL-1β production is surprisingly prominent in both P2X
−/−
7
and P2X
−/−
4 mice exposed to uropathogenic E. coli. This
underscores that IL-1β production in this model can occur
P2X7R-independently. Numerous studies have indicated that
the NOD-like receptor family pyrin domain containing 3
(NLRP3) inflammasome can be activated by casp8 leading to
pro-IL-1β processing (Gringhuis et al., 2012; Gurung et al., 2014;
Antonopoulos et al., 2015). Interestingly, activation of casp8 can
occur P2X7 receptor independently (Felley et al., 2016) and thus,
may explain the IL-1β production in the P2X
−/−
7 mice. Casp8
deficiency in mice is embryonically lethal (Varfolomeev et al.,
1998) because casp8 suppresses receptor-interacting protein
kinase 3 (RIPK3) (Kang et al., 2013), which cause massive
inflammasome activation in Casp8−/− mice. Mice lacking both
casp8 and RIPK3 are, however, viable (Kaiser et al., 2011; Oberst
et al., 2011) and showed similar survival during 6-h observation
after iv-injection of ARD6 (high dose, Figure 7A). Strikingly, the
cytokine levels were substantially lower in casp8/RIPK3DKO mice
compared to controls following a low dose of ARD6 (Figure 7B).
Therefore, we tested how these mice manage a less severe
stimulus and mimicked severe inflammatory response syndrome
(SIRS) by intravenous injection of TNFα (25 µg kg−1). In these
experiments themice were not anesthetised during the procedure
and were carried out at Christian-Albrechts-University Kiel,
Germany under German legislation for animal experiments and
in accordance with the local committee for the preservation
of animal act. This procedure resulted in death of all wild
type mice within 36 h, whereas casp8/RIPK3DKO mice showed
a striking 100% survival (Figure 7C). RIPK3 deficiency alone
did not protect mice from dying of TNFα injection although
they showed a marginal increase in survival compared to wild
type. These data suggest an important upstream involvement
of casp8 in this model. We conclude that P2X-receptors are
crucial determinants for the outcome of sepsis induced by
HlyA-producing E. coli in mice. The increased immunoreactivity
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FIGURE 4 | The effect of P2X7 receptor inhibition in E. coli-induced sepsis. ARD6 was injected iv into anesthetized balb/cj mice (low dose—41 million). Two
hours prior to ARD6 injection the animals were administered the P2X7 antagonist BBG or vehicle (50mg kg
−1, subcutaneously). (A) Kaplan-Meier plot shows survival,
n = 6 for controls and 10–12 for ARD6 with or without BBG. (B) Absorbance of plasma as an indication of plasma haemolysis 2.5 h after ARD6 injection, n = 13 for all
four groups. (C) Colony forming units from blood samples 2.5 h after a low number of bacteria (D) Levels of the cytokines TNFα, KC, IL-1β, and IL-6 2.5 h after ARD6
injection, n = 14 for ARD6 and 13 for ARD6 + BBG. *p < 0.05.
in P2X7 and P2X4 deficient mice is likely to be mediated via
non-canonical activation of IL-1β via casp8.
DISCUSSION
Urinary infections are exceedingly common and often caused by
E. coli, known as the dominant facultative bacterial agent in the
normal intestinal flora. However, simple urinary infections can
progress to severe pyelonephritis and sepsis. The invasive, more
aggressive E. coli-strains responsible for these severe infections
are serotypically distinct from facultative strains and frequently
produce the virulence factor α-haemolysin (Cavalieri et al., 1984;
Bhakdi et al., 1988). A recent study showed that specific fine-
tuning of HlyA expression by the human cystitis isolate UTI189
alters the course of both acute and chronic urinary tract infection
in mice (Nagamatsu et al., 2015). In the present study, we
investigated acute sepsis in mice induced by an uropathogenic α-
haemolysin producing E. coli strain (ARD6). We chose to induce
sepsis by direct injection of live bacteria intravenously in mice,
since this model allow us to specifically choose the sepsis-causing
bacterium. The virulence factor HlyA is known to cause severe
cell damage in a P2X-receptor dependent fashion and thus, we
were interested in the role of three P2X receptors (P2X1, P2X4,
and P2X7) in sepsis caused by HlyA-producing, uropathogenic
E. coli.
IL-1β is a key cytokine in sepsis during which the plasma
levels of the cytokine can become exceedingly high (for review
see Dinarello, 2005). The NLRP3 inflammasome is essential
in processing and activation of IL-1β during inflammation
(Lamkanfi and Dixit, 2014) and a decrease in intracellular
K+ concentration is a prime activator of the inflammasome
(Cain et al., 2001; Munoz-Planillo et al., 2013). Stimulation
of ionotropic P2X7Rs on macrophages by ATP directly causes
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FIGURE 5 | P2X1 deficiency and P2X1 inhibition in E. coli-induced sepsis. ARD6 was injected into anesthetized P2X
+/+
1 and P2X
−/−
1 mice at a concentration
of either low (61 million) or high (248 million) number of bacteria. (A) Kaplan-Meier plot shows survival (high dose), n = 6 for control and n = 12 for both genotypes. (B)
Survival in the presence or absence of the P2X1 antagonist NF449 (100mg kg
−1, iv) in balb/c mice. The mice were exposed to the high concentration of bacteria, n
= 6 for control with or without NF449 and n = 10–12 for ARD6 with or without NF449. (C) Absorbance of plasma as an indication of plasma haemolysis after the low
dose, n = 8 for both genotypes (D) Levels of thrombin-antithrombin (TAT) complexes in plasma 2.5 h after the low dose, n = 8 for both genotypes. (E) Levels of TNFα,
KC, IL-1β, and IL-6 2.5 h after the low dose of ARD6, n = 13 both genotypes. *p < 0.05.
the K+ eﬄux and maturation and release of IL-1β (Perregaux
and Gabel, 1994; Kahlenberg and Dubyak, 2004; Lister et al.,
2007; Qu et al., 2007; Pelegrin et al., 2008; Wiley et al., 2011).
These findings prompted the concept that P2X7R antagonists
potentially could be used against inflammatory diseases of the
kidney, in rheumatoid arthritis and pain disorders (Arulkumaran
et al., 2011; Alves et al., 2013). Here, surprisingly we demonstrate
that P2X
−/−
7 mice have an enhanced susceptibility to sepsis
induced by uropathogenic E. coli with an increased mortality
compared to wild type mice. The coagulation cascade is
often activated alongside the immune system during sepsis
and results in thrombin formation and platelet activation (for
review see Brass, 2003). Thrombocytopenic mice are associated
with a higher systemic bacterial load, increased plasma levels
of pro-inflammatory cytokines (TNFα, IL-6, and IFN-γ) and
accordingly a poorer outcome of sepsis induced by Gram-
negative bacteria (van den Boogaard et al., 2015). In the present
study, we found an increased plasma level of TAT-complexes in
P2X
−/−
7 mice, which is associated with increase mortality during
sepsis (van den Boogaard et al., 2015). Increased mortality and
increased TAT were also found in the P2X4 deficient mice. Thus,
one may speculate that thrombocytopenia could be a part of
an immune deficiency in P2X
−/−
7 and P2X
−/−
4 mice. Moreover,
high plasma concentration of hemoglobin during sepsis is also
associated with increased mortality (Larsen et al., 2010; Adamzik
et al., 2012) and P2X
−/−
7 mice showed increased plasma levels
of hemoglobin compared to wild type. Thus, several risk factors
associated with poorer outcome was observed in our murine
model of urosepsis.
Previous studies from our group demonstrate a sizable
reduction of HlyA-induced cell damage by P2X receptor
antagonists on human and murine erythrocytes (Skals et al.,
2009, 2014) and monocytes (Fagerberg et al., 2016). Therefore,
it was exceedingly surprising to find that P2X
−/−
7 mice were
not relatively protected, but rather distinctively more sensitive
ARD6-induced sepsis. This contrasts with in vivo studies that
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FIGURE 6 | P2X4 deficiency in E. coli-induced sepsis. ARD6 was injected into anesthetized P2X
+/+
4 and P2X
−/−
4 mice at a concentration of either low (61
million) or high (248 million) bacteria. (A) Kaplan-Meier plot shows survival after the high dose, n = 5 for each genotypes (B) Level of haemolysis after the low dose, n
= 8 for P2X
+/+
4 and 6 for P2X
−/−
4 . (C) Levels of thrombin-antithrombin (TAT) complexes in plasma 2.5 h after the low dose of bacteria, n = 8 for each genotype. (D)
Levels of TNFα, KC, IL-1β, and IL-6 2.5 h after the low dose of ARD6, n = 11 both genotypes. *p < 0.05.
have shown improved survival of P2X
−/−
7 mice when sepsis
was induced by coecal ligation and puncture (Santana et al.,
2015), lipopolysaccharide (LPS)-injection (Yang et al., 2015)
and adenovirus infection (Lee et al., 2012). However, like in
the present study, decreased survival and a greater bacterial
load in the blood of P2X
−/−
7 mice subjected to coecal ligation
and puncture has been reported (Csoka et al., 2015). Thus,
P2X7 receptors have a critical role during sepsis and potential
survival of this critical condition is a fine balance of the
degree of inflammasome-activation and subsequent cytokine
production. Massive infection apparently reveals an immune
deficiency in P2X
−/−
7 mice, a notion generally supported by
the markedly smaller spleen in P2X
−/−
7 mice. Our study
clearly reveals acute splenomegaly in septic mice, which is
explained through a combination of the severe infection and
resultant intravascular erythrocyte damage. The tentatively
higher infection-induced splenomegaly in the P2X
−/−
7 fits the
lower survival rates, higher cytokine levels and intravascular
haemolysis. Interestingly, a recent study showed clear up-
regulation of the NLRP3 inflammasome pathway in primary
microglial and macrophages from P2X
−/−
7 mice (Franceschini
et al., 2015). Such an up-regulation may explain the higher
cytokine levels and the increased mortality in P2X
−/−
7 mice if
the NLRP3 inflammasome could be activated by an alternative
pathway to casp-1. It must be noted that neither of the available
P2X
−/−
7 mice are complete knockouts (Nicke et al., 2009; Masin
et al., 2012). This is the result of the many splice variations
of the P2X7 receptor. The splice variant still remaining in the
P2X
−/−
7 mice used in the current study is expressed in the spleen
(Nicke et al., 2009). It is, however, unlikely that the difference
between P2X
−/−
7 and the P2X7 antagonism would result from
this splice variation, because the mice in which some P2X7
receptor function is preserved show a worse outcome compared
to general inhibition of the receptor.
Strikingly, the P2X receptor antagonist BBG, did not reduce
the survival of sepsis induced by uropathogenic E. coli. On the
contrary, BBG showed a tendency toward prolonging survival
of infected mice and statistically significantly reduce plasma IL-
1β and TNFα following a low dose of ARD6. BBG was given
at a dose, which resulted in a plasma concentration known
to give maximal inhibition of both HlyA and complement
induced haemolysis in mice (Hejl et al., 2012). Essentially, one
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FIGURE 7 | Casp8 and RIPK3 deficiency in E. coli-induced sepsis and TNFα-induced shock. ARD6 was injected into anesthetized wild type and
casp8/RIPK3DKO mice at a low (61 million) or high concentration (248 million). (A) Kaplan-Meier plot shows survival after the high dose, n = 6 for wild type and 8 for
casp8/RIPK3DKO. (B) Levels of TNFα, KC, IL-1β and IL-6 2.5 h after the low dose of ARD6, n = 7 for wild type and 6 for casp8/RIPK3DKO. (C) Kaplan-Meier plot
shows survival after TNFα shock (25mg kg−1) was induced in wildtype, RIPK3 deficient and casp8/RIPK3DKO, n = 8 in all three groups. *p < 0.05.
could imagine that acute inhibition of P2X7 may have other
consequences. However, although BBG is primarily used as a
P2X7antagonist, it also inhibits P2X1 and P2X4 receptors (Jiang
et al., 2000; Seyffert et al., 2004). Thus, if either P2X1 or P2X4
receptors oppose the effect of P2X7 in sepsis, it may potentially
explain the discrepancy between the P2X
−/−
7 and the results
obtained with BBG. Interestingly, we found that specific lack of
P2X1 receptors considerably reduced level of the cytokines TNFα,
IL-1β, and IL-6 and lowered coagulation activation following the
low dose of ARD6. Notably, the P2X1 mouse is on a C57BL/6
background, which has a loss of functionmutation in the P2X7, at
least in the splice variant expressed in T lymphocytes (Adriouch
et al., 2002) and is deficient in NLRP-1 (Boyden and Dietrich,
2006), which both may oppose the effect of P2X1 deficiency.
Two recent studies where sepsis-like conditions were induced
in P2X
−/−
1 mice show contradicting results. One study showed
increased survival in P2X
−/−
1 mice after LPS injection (10mg
kg−1) (Maitre et al., 2015), while another demonstrated decreased
survival after injection of 20mg kg−1 LPS (Lecut et al., 2012) in
mice lacking P2X1 receptors. Since both these studies also had
P2X
−/−
1 on a C57BL/6 background and thus, a less functioning
P2X7 receptor, this may explain the higher sensitivity in the
mice at higher dose of LPS. In mice pre-treated with NF449
there was no difference in intravascular haemolysis or cytokine
levels in plasma (data not shown), which is likely to result
from inadequate blockage of the receptor as previously suggested
from the substance pharmacokinetics (Hechler et al., 2005).
Thus, there may be room for a specific P2X1 antagonist with a
prolonged effect in the supportive therapy of septic conditions,
since it is very likely that the effect of BBG is mediated through
P2X1 receptor inhibition.
The P2X4 receptor is also known to be expressed inmonocytes
and macrophages (Kawano et al., 2006) and to influence cytokine
release and cell death via P2X7-dependent mechanisms (Kawano
et al., 2006; Perez-Flores et al., 2015). Thus, activation of the
P2X4 receptor in macrophages may have similar effects as the
P2X7 receptor in terms of macrophage function including IL-1β
release and apoptosis. This study supports a similar function of
P2X7 and P2X4 receptors in the acute septic response. Similar
to the P2X7 receptor, P2X
−/−
4 mice died earlier upon exposure
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to HlyA-producing E. coli and showed an increased level of IL-
1β. Though the finding from P2X
−/−
4 mice cannot explain the
discrepancy between the P2X
−/−
7 and BBG data, these data point
to an important function of P2X4Rs in acute severe infection.
The question is; what causes the high cytokine levels,
particularly of IL-1β in P2X
−/−
7 mice? As previously mentioned
P2X7 has a central role in activation of casp1 and the final
cleavage of pro-IL-1β to the active form. However, natural killer
cells can induce P2X7 receptor-independent monocyte IL-1β
release via activation of both casp1 and casp8 (Felley et al., 2016).
Casp8 plays an essential role during apoptosis, necroptosis and
NLRP3 activation (Mocarski et al., 2011) and has recently been
demonstrated to cause cytokine release in a murine model of
LPS-induced shock (Oliva-Martin et al., 2016). Mice deficient
of casp8 are not viable, which is most likely because casp8
normally suppresses RIPK3 depended necroptosis. Thus, we used
the viable casp8/RIPK3DKO and demonstrate that the levels of
TNFα, KC, IL-6, and IL-1β were markedly suppressed compared
to wild type controls. Despite that we only observed a tendency
toward increased survival after this acute, massive infection with
uropathogenic E. coli, a marked effect of lack of casp8 was
observed, if we used a milder model of septic shock—injection of
TNFα. Thus, casp8 is readily activated during sepsis induced by
HlyA-producing E. coli and this pathway may very well explain
the cytokine production in the P2X7 deficient mice.
In summary, our data demonstrate enhanced susceptibility to
sepsis with HlyA-producing E. coli in mice lacking P2X7 and
P2X4 receptors, whereas mice lacking P2X1 receptors exhibit
lower cytokine levels during this condition. Elevated plasma
levels of the pro-inflammatory cytokines, free hemoglobin and
activation of the coagulation system could potentially explain
the poorer outcome of sepsis in the P2X
−/−
7 and P2X
−/−
4
mice. Interestingly, this sepsis model strongly activates the non-
canonical inflammasome pathway via casp8 short-circuiting the
classical P2X7 dependent activation of casp1. Deficiency of this
pathway completely prevents the infection induced cytokine
response. These surprising and new results provide an additional
insight into the pathogenesis in sepsis and for new ways to
approach the condition pharmacologically.
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